These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9146775

  • 21. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
    Brummer RJ, Geerling BJ, Stockbrügger RW.
    Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
    [Abstract] [Full Text] [Related]

  • 22. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 23. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB, Van Oene JC.
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [Abstract] [Full Text] [Related]

  • 24. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.
    Smout AJ, Jonkman JH, Peeters PA, De Bruin H.
    Aliment Pharmacol Ther; 1995 Feb; 9(1):51-6. PubMed ID: 7766744
    [Abstract] [Full Text] [Related]

  • 25. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.
    Florent C, Forestier S.
    Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634
    [Abstract] [Full Text] [Related]

  • 26. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF, Fraser R, Armstrong D, Blum AL.
    Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
    [Abstract] [Full Text] [Related]

  • 27. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
    Robinson M, Sahba B, Avner D, Jhala N, Greski-Rose PA, Jennings DE.
    Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
    [Abstract] [Full Text] [Related]

  • 28. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
    Inatomi N, Murakami I, Asano S, Inada I, Satoh H.
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):333-43. PubMed ID: 9017687
    [Abstract] [Full Text] [Related]

  • 29. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 30. Effects of a single low dose of ranitidine and effervescent antacids on intragastric acidity in healthy volunteers.
    Améndola R, Santos MC, Massa JM, Vazquez H, Smecuol E.
    Acta Gastroenterol Latinoam; 2007 Dec 26; 37(4):231-7. PubMed ID: 18254261
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov 26; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M, Kato M, Sato Y, Miyazaki T.
    Nihon Rinsho; 1992 Jan 26; 50(1):104-10. PubMed ID: 1347322
    [Abstract] [Full Text] [Related]

  • 39. [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
    Serebrova SIu.
    Klin Med (Mosk); 2007 Jan 26; 85(3):61-4. PubMed ID: 17523409
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.